EngageRX Selected as Winner of Alpha Startups™ 64 Cohort

KUALA LUMPUR, Malaysia — EngageRX is proud to announce its selection as one of the winners of the Alpha Startups™ 64 Cohort, a prestigious pre-accelerator program run by 1337 Ventures, one of Southeast Asia's leading early-stage venture capital firms.

This achievement marks a significant milestone for EngageRX as it continues its mission to transform pharmaceutical sales through intelligent automation and AI-powered solutions. The company was selected alongside other innovative startups including Fluxion, from a highly competitive pool of applicants across the region.

"We are truly honored to be selected as one of the winners. This recognition fuels our mission to redefine pharmaceutical sales and deliver meaningful value to our clients."

— Natalie Kwok, Founder, EngageRX

World-Class Mentorship and Support

As part of the Alpha Startups™ program, EngageRX received guidance from industry veterans and successful entrepreneurs, including mentors Eng Ruo Ni and Bikesh Lakhmichand. The 1337 Ventures team, including Narayani Raj, Shannon Chow, and Low Ler Min, provided invaluable support throughout the accelerator journey.

About EngageRX

EngageRX is an AI-powered sales automation platform designed specifically for pharmaceutical companies. Our solution enables pharma sales teams to reach more healthcare professionals efficiently, maintain consistent engagement, and drive better outcomes through intelligent automation.

By leveraging advanced AI technology, EngageRX helps pharmaceutical companies overcome traditional sales challenges including limited reach, high costs, and inconsistent follow-up, while ensuring compliance and personalization at scale.

About 1337 Ventures

1337 Ventures is a leading early-stage venture capital firm in Southeast Asia, focused on discovering and nurturing the region's most promising startups. Through their Alpha Startups™ program, they provide pre-seed funding, mentorship, and access to a vast network of investors and industry leaders.

Looking Ahead

With this recognition and support from 1337 Ventures, EngageRX is positioned to accelerate its growth and expand its impact in the pharmaceutical industry. The company remains committed to its vision of empowering pharmaceutical sales teams with intelligent, scalable, and efficient solutions.

EngageRX extends its gratitude to the judges, mentors, and the entire 1337 Ventures team for believing in our vision. We look forward to the exciting journey ahead as we continue to build and scale our solution together.